Debora Jorn

Biography

Debora Jorn has served as a member of the Viveve board of directors since May, 2016. Ms. Jorn has 30 plus years of commercial experience building multi-billion dollar U.S. and global pharmaceutical and OTC businesses. Deb is a recognized leader in creating new markets and successfully launching products in numerous therapeutic areas. She is an expert commercial strategist who has led the consumer and physician marketing efforts for such iconic brands as Detrol LA, Ocuvite, Nasonex, Nuvaring, Jublia and Xifaxan. She also has an extensive background in several areas of Women’s Healthcare including overactive bladder, fertility, contraception, IBS-D and osteoporosis. Most recently, Deb was Executive Vice President and Group Company Chair at Valeant where she had responsibility for the Dermatology and Gastrointestinal businesses. Prior to that, she was the Chief Global Marketing Officer at Bausch & Lomb leading the prescription and OTC eye health business. Before joining Bausch & Lomb, Deb was the Group Vice President of Women’s Healthcare and Fertility at Schering Plough Corporation. She has a strong scientific background and extensive experience in all facets of the clinical development process leading to product launch including: market and competitive assessments, clinical strategy and trial design, labeling requirements for approval and competitive differentiation. PharmaVoice has recognized Ms. Jorn as “one of the top 100 most inspiring people in healthcare” in the “brand builders” category.

Research Interest

medical